rs7329174: Understanding This Genetic Variant and Breast Carcinoma
The genetic variant rs7329174 is a single nucleotide polymorphism located in an intergenic region of the human genome. It has been identified in genome-wide association studies as being associated with susceptibility to breast carcinoma.
What each genotype means
Baseline risk profile
This genotype represents the common baseline state for this genetic location. Current research does not indicate that this specific combination of alleles significantly alters your susceptibility to breast carcinoma compared to the general population.
This is the most common genotype observed in most global populations.
Potential risk association
This genotype has been identified in genome-wide association studies as being linked to breast carcinoma susceptibility. Because this association is based on statistical trends across large groups, it does not provide a definitive prediction for your individual health outcomes.
This genotype is found at varying frequencies depending on ancestral background, appearing in a significant minority of individuals in many populations.
Potential risk association
This genotype has been identified in genome-wide association studies as being linked to breast carcinoma susceptibility. As this is a complex trait influenced by many genetic and environmental factors, this result should be viewed as a statistical observation rather than a diagnostic indicator.
This genotype is less common than the baseline AA genotype and its frequency varies significantly across different ancestral groups.
What is rs7329174?
The identifier rs7329174 refers to a specific single nucleotide polymorphism (SNP) in the human genome. A SNP is a variation at a single position in a DNA sequence among individuals. This particular variant is classified as intergenic, meaning it is located in the DNA sequence between genes rather than within a gene that codes for a protein. Because it sits in these non-coding regions, researchers often investigate whether such variants might play a role in regulating the expression of nearby genes, though the functional consequences of rs7329174 remain a subject of ongoing scientific inquiry.
Association with Breast Carcinoma
The primary interest in rs7329174 stems from its inclusion in genome-wide association studies (GWAS) that have linked it to breast carcinoma susceptibility. GWAS are large-scale research efforts that scan the genomes of many people to find small variations associated with specific traits or diseases. While these studies provide valuable statistical evidence, it is important to understand that an association does not imply direct causation. The evidence strength for this specific variant is currently considered moderate, reflecting that while a statistical signal has been observed, the biological mechanism by which this variant might influence cancer risk is not yet fully understood or established in clinical literature.
Interpreting Genetic Associations
When researchers report that a variant like rs7329174 is associated with a condition, they are describing a correlation observed in a population. This information is used by scientists to better understand the complex genetic architecture of diseases. However, for an individual, this information is not a diagnostic tool. Breast cancer is a multifactorial condition influenced by a combination of genetics, lifestyle, and environmental factors. Having a specific genotype at this location does not mean an individual will or will not develop a condition. Genetic data should always be interpreted in the context of a person's overall health history and in consultation with a qualified healthcare professional.
What You Can Do With This Information
If you have received information about your status for rs7329174, it is best to view it as a piece of general scientific data rather than a personal medical directive. Because the association is based on population-level statistics, it cannot predict individual health outcomes. You cannot use this information to diagnose yourself or to make changes to your medical care. If you are concerned about your risk for breast cancer, the most effective steps involve discussing your family history and personal health profile with a doctor or a genetic counselor. They can provide personalized guidance on appropriate screening schedules and risk-reduction strategies based on established clinical guidelines, which are far more reliable than any single genetic variant.
How common is this variant?
The frequency of the alleles for rs7329174 is known to be variable across different ancestral populations, as is common with many non-coding genetic variants.
Frequently asked questions
Is rs7329174 a diagnostic test for breast cancer?
No, rs7329174 is not a diagnostic test. It is a genetic variant identified in research studies as having a statistical association with breast cancer risk, but it does not determine whether an individual will develop the disease.
Should I be worried if I have the risk allele for rs7329174?
Genetic associations found in GWAS are typically very small and do not provide enough information to assess individual risk. You should not be worried based on this single variant; instead, focus on standard health screenings recommended by your physician.
Where can I find more information about this variant?
You can find technical information about this variant in the GWAS Catalog or the NCBI dbSNP database. These resources provide data on the studies that have investigated the variant.
Does this variant affect how I should be treated for cancer?
There is no evidence that rs7329174 should influence clinical treatment decisions. Always discuss any questions regarding cancer treatment or screening with your oncologist or primary care provider.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7329174?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This SNP acts as an intermediate allele tag for the C9orf72 repeat expansion, which is linked to both ALS risk and longevity outcomes.
This variant in the CDKN2B-AS1 long noncoding RNA gene is associated with extreme longevity in genome-wide association studies.
This variant has been identified as a shared genetic signal between longevity and Alzheimer's disease risk.
A variant in the ALOX5 gene associated with potential modulation of inflammatory responses to dietary factors.
This SNP is linked to cardiovascular disease prevention strategies and personalized nutritional approaches.
This polymorphism in the arachidonate 5-lipoxygenase gene is investigated for its potential influence on cardiovascular disease risk and dietary response.